New Zealand may begin publicly funding CAR T-cell therapy within one to two years, enabling access for blood cancer patients after years of reliance on international trials.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
government planning for future rollout
CAR T-cell therapy in New Zealand: When will blood cancer patients get access?Social-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.